Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells

by palligoelme@gmail.com | Apr 2, 2025 | Clinical Trials

​ Conditions: Primary Myelofibrosis Interventions: Other: In vitro culture Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Recruiting Conditions: Primary Myelofibrosis Interventions: Other: In vitro culture Sponsors: Fondazione IRCCS Policlinico San Matteo...

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

by palligoelme@gmail.com | Apr 1, 2025 | Clinical Trials

​ Conditions: Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements; Recurrent High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements;...

Effects of Antenatal Education on Birth Perception, Fear, and Readiness

by palligoelme@gmail.com | Apr 1, 2025 | Clinical Trials

​ Conditions: Childbirth; Fear Interventions: Behavioral: Transformational Learning-Based Antenatal Education Program Sponsors: Kastamonu University Completed Conditions: Childbirth; Fear Interventions: Behavioral: Transformational Learning-Based Antenatal Education...

The Effects of Eccentric Compared to Standard Strength Training in Primary Spinal Cord Injury Rehabilitation

by palligoelme@gmail.com | Apr 1, 2025 | Clinical Trials

​ Conditions: Spinal Cord Injury Interventions: Procedure: Eccentric (KREHA) training; Procedure: Standard clinical routine strength (STAN) training Sponsors: Swiss Paraplegic Research, Nottwil Not yet recruiting Conditions: Spinal Cord Injury Interventions:...

Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments

by palligoelme@gmail.com | Apr 1, 2025 | Clinical Trials

​ Conditions: Dry Eye Disease (DED); Graft-Versus-Host Disease(GVHD) Interventions: Drug: Subconjuntival injection of expanded allogenic adult adipose tissue-derived mesenchymal stem cells (ASC Sponsors: Instituto de Investigación Biomédica de Salamanca; Spanish...